911 related articles for article (PubMed ID: 27794493)
1. Hybrid protein-inorganic nanoparticles: From tumor-targeted drug delivery to cancer imaging.
Elzoghby AO; Hemasa AL; Freag MS
J Control Release; 2016 Dec; 243():303-322. PubMed ID: 27794493
[TBL] [Abstract][Full Text] [Related]
2. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
3. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
4. Inorganic Nanoparticles for Cancer Therapy: A Transition from Lab to Clinic.
Bayda S; Hadla M; Palazzolo S; Riello P; Corona G; Toffoli G; Rizzolio F
Curr Med Chem; 2018; 25(34):4269-4303. PubMed ID: 29284391
[TBL] [Abstract][Full Text] [Related]
5. Inorganic nanoparticles for cancer imaging and therapy.
Huang HC; Barua S; Sharma G; Dey SK; Rege K
J Control Release; 2011 Nov; 155(3):344-57. PubMed ID: 21723891
[TBL] [Abstract][Full Text] [Related]
6. Protein-inorganic Nanohybrids: A Potential Symbiosis in Tissue Engineering.
Freag MS; Elzoghby AO
Curr Drug Targets; 2018; 19(16):1897-1904. PubMed ID: 29076428
[TBL] [Abstract][Full Text] [Related]
7. Recent advances in theranostic nanocarriers of doxorubicin based on iron oxide and gold nanoparticles.
Gautier J; Allard-Vannier E; Munnier E; Soucé M; Chourpa I
J Control Release; 2013 Jul; 169(1-2):48-61. PubMed ID: 23567046
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
9. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
Revia RA; Stephen ZR; Zhang M
Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
[TBL] [Abstract][Full Text] [Related]
10. Cell membrane-coated nanocarriers: the emerging targeted delivery system for cancer theranostics.
Bose RJ; Paulmurugan R; Moon J; Lee SH; Park H
Drug Discov Today; 2018 Apr; 23(4):891-899. PubMed ID: 29426004
[TBL] [Abstract][Full Text] [Related]
11. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine for cancer diagnosis and therapy: advancement, success and structure-activity relationship.
Bhise K; Sau S; Alsaab H; Kashaw SK; Tekade RK; Iyer AK
Ther Deliv; 2017 Nov; 8(11):1003-1018. PubMed ID: 29061101
[TBL] [Abstract][Full Text] [Related]
13. Emergence of nanomedicine as cancer targeted magic bullets: recent development and need to address the toxicity apprehension.
Rahman M; Ahmad MZ; Kazmi I; Akhter S; Afzal M; Gupta G; Sinha VR
Curr Drug Discov Technol; 2012 Dec; 9(4):319-29. PubMed ID: 22725687
[TBL] [Abstract][Full Text] [Related]
14. Advances in inorganic nanoparticles-based drug delivery in targeted breast cancer theranostics.
Rahimkhoei V; Alzaidy AH; Abed MJ; Rashki S; Salavati-Niasari M
Adv Colloid Interface Sci; 2024 Jul; 329():103204. PubMed ID: 38797070
[TBL] [Abstract][Full Text] [Related]
15. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
16. Anisotropic noble metal nanoparticles: Synthesis, surface functionalization and applications in biosensing, bioimaging, drug delivery and theranostics.
Paramasivam G; Kayambu N; Rabel AM; Sundramoorthy AK; Sundaramurthy A
Acta Biomater; 2017 Feb; 49():45-65. PubMed ID: 27915023
[TBL] [Abstract][Full Text] [Related]
17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
18. Hybrid Nanoplatforms Comprising Organic Nanocompartments Encapsulating Inorganic Nanoparticles for Enhanced Drug Delivery and Bioimaging Applications.
Yanar F; Carugo D; Zhang X
Molecules; 2023 Jul; 28(15):. PubMed ID: 37570666
[TBL] [Abstract][Full Text] [Related]
19. Immune Cell-Mediated Biodegradable Theranostic Nanoparticles for Melanoma Targeting and Drug Delivery.
Xie Z; Su Y; Kim GB; Selvi E; Ma C; Aragon-Sanabria V; Hsieh JT; Dong C; Yang J
Small; 2017 Mar; 13(10):. PubMed ID: 28026115
[TBL] [Abstract][Full Text] [Related]
20. Multicolorful Carbon Dots for Tumor Theranostics.
Wang H; Bi J; Zhu BW; Tan M
Curr Med Chem; 2018; 25(25):2894-2909. PubMed ID: 28302015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]